AD is a growing market with an impressive pipeline of new products from current and future players in the field.

Atopic dermatitis, asthma, and allergic rhinitis are among the allergic diseases tied to a significantly increased risk for ...

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar.

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ex-Dermira executives.

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

AbCellera faces challenges as it shifts to internal development, impacting revenue. It retains a large cash position. Read ...

Have you ever experienced morning foot pain, swollen feet or dry, flaking skin but shrugged it off or simply put it down to ...

In 2021, Serrat launched Violette_FR, a multicategory beauty brand, which has gained a cult-like following. Earlier this year ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

Everybody loves a quick fix and if it’s easy and affordable, all the better. A seemingly recent trend that in fact has been ...